Logo

Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests. 

Nov 1, 2022

Myriad Genetics to Submit Hereditary Cancer Risk Variants to ClinVar in 2023
Premium

Oct 19, 2022

Veto of California Bill Mandating Payor Coverage of Biomarker Tests Sparks Stakeholder Debate
Premium

Oct 18, 2022

AMP, CAP Release Guidelines for Use of In Silico Approaches for Validating NGS Data Pipelines

Oct 17, 2022

Polygenic Risk Scores Could Refine Breast Cancer Screening Recommendations
Premium

Oct 5, 2022

California Governor Vetoes Biomarker Test Coverage Bill

Oct 4, 2022

Nonprofit's Efforts With Payors to Assess NGS Labs' Variant Interpretations Spark Debate
Premium

Oct 3, 2022

Highmark Asks Labs for Additional Validation Data on Cancer NGS Tests; Will Other Insurers Follow?
Premium

Sep 30, 2022

Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients

Sep 21, 2022

Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients

Sep 12, 2022

ESMO Data Sharpens View of How Grail, Exact Sciences Multi-Cancer Early Detection Tests Perform
Premium

Sep 7, 2022

BostonGene, Mass General Hospital Cancer Center Form Research Alliance

Sep 7, 2022

Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain
Premium

Aug 29, 2022

Genome Insight, Ajou University Medical Center to Test WGS Use for Routine Cancer Care

Aug 18, 2022

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium

Aug 8, 2022

CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection
Premium

Aug 8, 2022

Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation

Aug 3, 2022

Exact Sciences Partners With West German Study Group to Validate MRD Test in Breast Cancer

Aug 2, 2022

Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer

Jul 29, 2022

Stakeholders Urge Collaboration to Prove ctDNA as Regulatory Endpoint for Early Cancer Drugs
Premium

Jul 28, 2022

Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma